• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者血清肌酐正常的肾脏疾病。

Renal disease in systemic sclerosis with normal serum creatinine.

机构信息

Department of Rheumatology and Rehabilitation, Faculty of medicine, Cairo University, Cairo, Egypt.

出版信息

Clin Rheumatol. 2010 Jul;29(7):729-37. doi: 10.1007/s10067-010-1389-3. Epub 2010 Feb 23.

DOI:10.1007/s10067-010-1389-3
PMID:20174989
Abstract

Prognosis of systemic sclerosis largely depends on involvement of internal organs. The aim was to evaluate renal impairment in patients with systemic sclerosis by measuring the Glomerular filteration rate (GFR) and then calculating the GFR using the Cockgroft and Gault formula and the Modification of Diet in Renal Disease Equation (MDRD) formula. Thirty one scleroderma patients were recruited from the Rheumatology and Rehabilitation Department, Cairo University Hospitals, mean age 43.25 +/- 11.28 years, 31 healthy controls were included. Disease severity was done using Medsger score. GFR was measured using classical Gates method TC99mDTPA. The modified Cockcroft and Gault formula and equation 7 from the MDRD were used for calculation of GFR. All patients had within normal serum creatinine levels. A normal GFR (>89ml/min) was found in 45.1%. Gates method showed reduced GFR was reported in 54.9%. Stage II chronic kidney disease (60-89 ml/min) found 32.3%, and stage III (30-59 ml/min) in 22.6%. The formulae used showed reduction of GFR in 35.29% of those affected by the Cockcroft-Gault and in 41.17% of those affected using the MDRD. No correlation to patients' age, disease duration, or severity. A positive correlation was also reported between the presence of renal involvement and pulmonary vascular involvement p = 0.04. Gates method showed reduction of the GFR in 54.9% of the systemic sclerosis patients. The formulae used were not as precise as the measured GFR in diagnosing all cases with subclinical renal involvement. Patients with systemic sclerosis should be screened for renal involvement irrespective of disease severity or duration.

摘要

系统性硬化症的预后在很大程度上取决于内脏器官的受累情况。本研究旨在通过测量肾小球滤过率(GFR),然后使用 Cockcroft 和 Gault 公式以及改良肾脏病饮食方程(MDRD)公式计算 GFR,来评估系统性硬化症患者的肾功能损害。从开罗大学医院风湿病和康复科招募了 31 名硬皮病患者,平均年龄为 43.25±11.28 岁,纳入 31 名健康对照者。使用 Medsger 评分评估疾病严重程度。使用经典的 TC99mDTPA Gates 方法测量 GFR。使用改良的 Cockcroft 和 Gault 公式和 MDRD 方程 7 计算 GFR。所有患者的血清肌酐水平均在正常范围内。45.1%的患者发现正常 GFR(>89ml/min)。Gates 方法显示 54.9%的患者 GFR 降低。发现 32.3%的患者患有慢性肾脏病 2 期(60-89ml/min),22.6%的患者患有慢性肾脏病 3 期(30-59ml/min)。受 Cockcroft-Gault 影响的患者中有 35.29%,受 MDRD 影响的患者中有 41.17%的患者的公式显示 GFR 降低。与患者年龄、疾病持续时间或严重程度无相关性。还报告了肾功能损害与肺血管受累之间存在正相关,p=0.04。Gates 方法显示 54.9%的系统性硬化症患者 GFR 降低。在诊断所有亚临床肾受累病例时,使用的公式不如测量的 GFR 精确。无论疾病严重程度或持续时间如何,系统性硬化症患者均应进行肾受累筛查。

相似文献

1
Renal disease in systemic sclerosis with normal serum creatinine.系统性硬化症患者血清肌酐正常的肾脏疾病。
Clin Rheumatol. 2010 Jul;29(7):729-37. doi: 10.1007/s10067-010-1389-3. Epub 2010 Feb 23.
2
Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment.计算的肾小球滤过率是识别硬皮病肾功能损害患者的一种有用的筛查工具。
Rheumatology (Oxford). 2003 Jan;42(1):26-33. doi: 10.1093/rheumatology/keg023.
3
Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.肾病饮食改良法与Cockcroft-Gault方程在抗菌药物给药剂量计算方面的比较。
Pharmacotherapy. 2009 Jun;29(6):649-55. doi: 10.1592/phco.29.6.649.
4
Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.高龄老人血清胱抑素C浓度与肾小球滤过率其他标志物的比较。
J Am Geriatr Soc. 2002 Jul;50(7):1278-82. doi: 10.1046/j.1532-5415.2002.50317.x.
5
[Obesity as a risk factor of chronic kidney disease in patients undergoing primary angioplasty].[肥胖作为接受初次血管成形术患者慢性肾病的一个风险因素]
Pol Arch Med Wewn. 2006 Oct;116(4):916-23.
6
GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.使用MDRD方程以及Cockcroft和Gault方程对终末期肾病患者的肾小球滤过率进行预测。
Nephrol Dial Transplant. 2005 Nov;20(11):2394-401. doi: 10.1093/ndt/gfi076. Epub 2005 Aug 22.
7
Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis.抗磷脂抗体与系统性硬化症患者的肾脏受累情况
Clin Rheumatol. 2009 Aug;28(8):955-9. doi: 10.1007/s10067-009-1188-x. Epub 2009 May 13.
8
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation.健康受试者和正常白蛋白尿糖尿病患者肾小球滤过率的评估:一种新的(MDRD)预测方程的有效性
Nephrol Dial Transplant. 2002 Nov;17(11):1909-13. doi: 10.1093/ndt/17.11.1909.
9
Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma.硬皮病患者肾扫描肾小球滤过率与估计方程的相关性
Am J Med Sci. 2016 Aug;352(2):166-71. doi: 10.1016/j.amjms.2016.04.017. Epub 2016 Apr 22.
10
Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population.血清肌酐正常但肾功能受损人群的特征以及:MDRD公式在健康普通人群中的验证
Clin Nephrol. 2005 Apr;63(4):258-66. doi: 10.5414/cnp63258.

引用本文的文献

1
Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients - a 24-month observation.抗磷脂抗体阳性对一组系统性硬化症患者肾小球滤过率标志物的影响——一项为期24个月的观察
Cent Eur J Immunol. 2017;42(2):161-166. doi: 10.5114/ceji.2017.69358. Epub 2017 Aug 8.
2
Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.使用血管紧张素转换酶抑制剂和糖皮质激素治疗的动脉高血压是系统性硬化症中与肾小球滤过率降低相关的独立危险因素。
Rheumatol Int. 2017 Mar;37(3):363-368. doi: 10.1007/s00296-016-3632-y. Epub 2016 Dec 22.
3

本文引用的文献

1
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis].[血管发生与血管生成:系统性硬化症中的血管损伤]
Reumatismo. 2009 Apr-Jun;61(2):81-3. doi: 10.4081/reumatismo.2009.81.
2
The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.血小板对大量血管内皮生长因子的运输突显了它们在系统性硬化症血管生成中的潜在作用。
Rheumatology (Oxford). 2009 Sep;48(9):1036-44. doi: 10.1093/rheumatology/kep154. Epub 2009 Jun 23.
3
Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis.
Scleroderma renal crisis and renal involvement in systemic sclerosis.
硬皮病性肾危象与系统性硬化症的肾脏受累。
Nat Rev Nephrol. 2016 Nov;12(11):678-691. doi: 10.1038/nrneph.2016.124. Epub 2016 Sep 19.
4
Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?^99m^Tc-二乙三胺五乙酸(DTPA):用于评估甲氨蝶呤在类风湿关节炎患者中引起的累积性肾滤过影响是否可靠?
Rheumatol Int. 2013 Dec;33(12):3059-63. doi: 10.1007/s00296-012-2620-0. Epub 2012 Dec 23.
5
Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.硬皮病中的肾脏疾病:评估、风险分层、发病机制和治疗的最新进展。
Curr Opin Rheumatol. 2012 Nov;24(6):669-76. doi: 10.1097/BOR.0b013e3283588dcf.
6
Tc-99m diethylenetriamine pentaacetic acid (DTPA) renal function reserve estimation: is it a reliable predictive tool for assessment of preclinical renal involvement in scleroderma patients?^99m^Tc-二乙三胺五乙酸(DTPA)肾功能储备评估:对于评估硬皮病患者临床前肾脏受累,它是一种可靠的预测工具吗?
Clin Rheumatol. 2012 Jun;31(6):961-6. doi: 10.1007/s10067-012-1963-y. Epub 2012 Feb 24.
7
Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.硬皮病的肾脏表现:亚临床肾脏疾病作为血管病变标志物的证据
Int J Rheumatol. 2010;2010. doi: 10.1155/2010/538589. Epub 2010 Aug 17.
抗磷脂抗体与系统性硬化症患者的肾脏受累情况
Clin Rheumatol. 2009 Aug;28(8):955-9. doi: 10.1007/s10067-009-1188-x. Epub 2009 May 13.
4
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.血清血管内皮生长因子水平与系统性硬化症患者肺动脉高压的存在有关。
BMC Pulm Med. 2009 May 9;9:18. doi: 10.1186/1471-2466-9-18.
5
Is scleroderma a vasculopathy?硬皮病是一种血管病吗?
Curr Rheumatol Rep. 2009 Apr;11(2):103-10. doi: 10.1007/s11926-009-0015-3.
6
Diagnosis, management and prevention of scleroderma renal disease.硬皮病肾病的诊断、管理与预防
Curr Opin Rheumatol. 2008 Nov;20(6):692-6. doi: 10.1097/BOR.0b013e3283108df7.
7
Renal manifestations of systemic sclerosis--clinical features and outcome assessment.系统性硬化症的肾脏表现——临床特征与结局评估
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v54-6. doi: 10.1093/rheumatology/ken307.
8
Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation.基于血清肌酐的肾小球滤过率公式的可靠性,特别提及肾脏病饮食改良(MDRD)研究方程。
Scand J Clin Lab Invest Suppl. 2008;241:30-8. doi: 10.1080/00365510802141140.
9
Isotopic scan for diagnosis of renal disease.用于肾病诊断的同位素扫描。
Saudi J Kidney Dis Transpl. 2004 Jul-Sep;15(3):257-64.
10
ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the "normotensive scleroderma renal crisis".系统性硬化症中与抗中性粒细胞胞浆抗体相关的新月体性肾小球肾炎:重新审视“血压正常的硬皮病肾危象”
Clin Nephrol. 2007 Sep;68(3):165-70. doi: 10.5414/cnp68165.